CNA Financial’s Teva Pharmaceuticals TEVA Stock Holding History

CNA Financial’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-53,000	Closed	-$2.44M	–	174
2016 Q3	$2.44M	Hold	53,000	–	–	0.56%	46
2016 Q2	$2.66M	Buy	+53,000	New	+$2.82M	0.66%	37
2015 Q2	–	Sell	-12,710	Closed	-$792K	–	194
2015 Q1	$792K	Hold	12,710	–	–	0.18%	134
2014 Q4	$731K	Sell	12,710 -19,060	-60%	-$1.06M	0.17%	137
2014 Q3	$1.71M	Sell	31,770 -4,320	-12%	-$229K	0.33%	90
2014 Q2	$1.89M	Sell	36,090 -8,365	-19%	-$428K	0.34%	91
2014 Q1	$2.35M	Hold	44,455	–	–	0.47%	63
2013 Q4	$1.78M	Hold	44,455	–	–	0.35%	88
2013 Q3	$1.68M	Sell	44,455 -12,025	-21%	-$469K	0.34%	88
2013 Q2	$2.21M	Buy	+56,480	New	+$2.2M	0.47%	57

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

CNA Financial's TEVA Position: Q4 2016 in Review

CNA Financial sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 53,000 shares — an estimated $2.44M sold.

CNA Financial first reported a position in TEVA in Q2 2013 and held it in 10 quarters. The position peaked at $2.66M in Q2 2016. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

CNA Financial reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
CNA Financial sold 53,000 Teva Pharmaceuticals shares in Q4 2016, an estimated $2.44M.
CNA Financial first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 10 quarters.
CNA Financial's Teva Pharmaceuticals position peaked at $2.66M in Q2 2016.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on CNA Financial's 13F filing for Q4 2016, filed 14 Feb 2017.